Tevogen Bio
Dr. Flomenberg is Professor and Chair of the Department of Medical Oncology and Deputy Director of Jefferson’s Sidney Kimmel Cancer Center. His career has focused on the care of patients with blood cancers, particularly those undergoing bone marrow or peripheral blood stem cell transplants. His laboratory and clinical research efforts have focused on improving our understanding of the challenges these patients face and developing innovative solutions to these problems. He has authored more than 175 peer reviewed publications.
His laboratory work was focused on cellular immunology, immunogenetics, and histocompatibility. He served as the organizer/leader of the cellular section of the Tenth International Histocompatibility Workshop.
In addition to his research, Dr. Flomenberg maintains an active practice and has been continuously listed in Philadelphia Magazine’s Top Doctors in Philadelphia and Castle Connolly’s America’s Top Doctors over the last 15 years. Under his leadership, Jefferson’s Department of Medical Oncology more than tripled in size, established a nationally recognized senior adult oncology program as well as an embedded Supportive Medicine and Survivorship Program, and has launched efforts to expand home chemotherapy administration and other cutting-edge care delivery models.
This person is not in any teams
This person is not in any offices
Tevogen Bio
2 followers
Tevogen Bio brings together a highly skilled team of preeminent scientists, senior biopharmaceutical leaders, and manufacturing experts with the goal of advancing global health. The company’s patient-centric mission is to leverage its proprietary cell and gene therapy platforms and novel business model to rapidly innovate breakthrough immunotherapies for cancers and viral infections with high unmet needs. Tevogen Bio’s foundational vision is a healthier world through equitable access to life-saving innovations.